Michel Guiguet
- Co-authors
- Jean‐Michel PetitPatrick HillonAnne MinelloJean‐Baptiste BourBruno VergèsJean-Marcel BrunOlivier CasasnovasDenis Caillot
- Topics
- Multiple Myeloma Research and Treatments (5 papers)Complement system in diseases (5 papers)Lymphoma Diagnosis and Treatment (3 papers)
- Partner nations
- France
In The Last Decade
Michel Guiguet
25 papers receiving 605 citations
Peers
Comparison fields: 5 of 87
- Epidemiology 221
- Hepatology 189
- Oncology 130
- Pathology and Forensic Medicine 119
- Molecular Biology 118
Countries citing papers authored by Michel Guiguet
This map shows the geographic impact of Michel Guiguet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Guiguet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Guiguet more than expected).
Fields of papers citing papers by Michel Guiguet
This network shows the impact of papers produced by Michel Guiguet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Guiguet. The network helps show where Michel Guiguet may publish in the future.
Co-authorship network of co-authors of Michel Guiguet
This figure shows the co-authorship network connecting the top 25 collaborators of Michel Guiguet. A scholar is included among the top collaborators of Michel Guiguet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel Guiguet. Michel Guiguet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 30 | |
| 3 | 2 | |
| 4 | Facteurs prédictifs de réponse virologique à un traitement antirétroviral avec inhibiteur de protéase au cours de l'infection à VIH | 1 |
| 5 | 213 | |
| 6 | 5 | |
| 7 | 2 | |
| 8 | 33 | |
| 9 | 7 | |
| 10 | 29 | |
| 11 | 3 | |
| 12 | 4 | |
| 13 | Human interleukin-6 acts as a co-factor for the up-regulation of C3 production by rat liver epithelial cells. | 5 |
| 14 | 56 | |
| 15 | 56 | |
| 16 | 7 | |
| 17 | 5 | |
| 18 | 13 | |
| 19 | 4 | |
| 20 | Proliferation kinetics of rabbit articular chondrocytes in primary culture and at the first passage. | 22 |
About Michel Guiguet
Michel Guiguet is a scholar working on Hematology, Pathology and Forensic Medicine and Immunology, having authored 25 papers that have together received 628 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (5 papers), Complement system in diseases (5 papers) and Lymphoma Diagnosis and Treatment (3 papers). The work is most often cited by research in Hepatology (189 citations), Hematology (91 citations) and Pathology and Forensic Medicine (119 citations). Michel Guiguet has collaborated with scholars based in France. Frequent co-authors include Jean‐Michel Petit, Patrick Hillon, Anne Minello, Jean‐Baptiste Bour, Bruno Vergès, Jean-Marcel Brun, Olivier Casasnovas, Denis Caillot, Éric Solary and P. Chavanet. Their work appears in journals such as Journal of Clinical Oncology, Analytical Biochemistry and The Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.